Metraipolis › archive › dc_ecde4b2e0748
NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting — Europe PMC PMID:40946102
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40946102
- DOI
- 10.1038/s41388-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T23:36:06.537Z
- SHA-256 of the archived text
8ed1ec0bbf8975256d5b2162d0b5dca61ae1854254294fed8155e8105e2a4013- Stable URL of this page
https://metraipolis.com/documento/dc_ecde4b2e0748
How to cite
NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting — Europe PMC PMID:40946102 — Europe PMC (en), https://europepmc.org/article/MED/40946102 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecde4b2e0748 (Metraipolis archive dc_ecde4b2e0748, sha256 8ed1ec0bbf8975256d5b2162d0b5dca61ae1854254294fed8155e8105e2a4013)
BibTeX
@misc{dcecde4b2e0748,
title = {NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting — Europe PMC PMID:40946102},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40946102},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecde4b2e0748; sha256 8ed1ec0bbf8975256d5b2162d0b5dca61ae1854254294fed8155e8105e2a4013},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40946102. Agents can read the archived copy with the MCP tool read_document.